[{"id":"fae4225c-f50d-4349-98d6-0d2136339eea","acronym":"","url":"https://clinicaltrials.gov/study/NCT04814056","created_at":"2021-03-24T15:11:24.734Z","updated_at":"2024-07-02T16:36:32.514Z","phase":"Phase 4","brief_title":"To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion","source_id_and_acronym":"NCT04814056","lead_sponsor":"Shanghai Chest Hospital","biomarkers":" NRG1","pipe":" | ","alterations":" NRG1 fusion • NRG1 fusion","tags":["NRG1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NRG1 fusion • NRG1 fusion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Gilotrif (afatinib)"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 06/01/2021","start_date":" 06/01/2021","primary_txt":" Primary completion: 09/29/2023","primary_completion_date":" 09/29/2023","study_txt":" Completion: 01/31/2024","study_completion_date":" 01/31/2024","last_update_posted":"2021-04-01"}]